| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/09537100802503368 |
| P698 | PubMed publication ID | 19172522 |
| P50 | author | Michael Bauer | Q50638837 |
| P2093 | author name string | Matthias Kohl | |
| Jürg Hamacher | |||
| Ralf A Claus | |||
| Johannes Winning | |||
| Wolfgang Lösche | |||
| Julia Reichel | |||
| Hans Peter Deigner | |||
| Yvonne Eisenhut | |||
| P2860 | cites work | Clinical trials in severe sepsis with drotrecogin alfa (activated) | Q21195024 |
| Serial evaluation of the SOFA score to predict outcome in critically ill patients | Q28191384 | ||
| Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin | Q28193127 | ||
| Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice | Q28193681 | ||
| In vivo platelet response to lipopolysaccharide in mice: proposed method for evaluating new antiplatelet drugs | Q28195590 | ||
| Platelet function and pharmacologic inhibition | Q28200441 | ||
| Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model | Q28212194 | ||
| Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease | Q28218124 | ||
| Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters | Q28219906 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Time course of platelet counts in critically ill patients. | Q33341888 | ||
| Platelet function in sepsis | Q33342364 | ||
| Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays | Q33375129 | ||
| Platelets: signaling cells in the immune continuum. | Q34342687 | ||
| The evolving role of platelets in inflammation. | Q35206747 | ||
| Platelets in sepsis | Q36270004 | ||
| New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates. | Q36425100 | ||
| Biology and pharmacology of the platelet P2Y12 receptor | Q36447310 | ||
| Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury | Q36667169 | ||
| Platelets as mediators of inflammation | Q36720126 | ||
| Effects of anticoagulant strategies on activation of inflammation and coagulation | Q36842724 | ||
| The role of platelet CD154 in the modulation in adaptive immunity | Q36961079 | ||
| Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis | Q37035362 | ||
| Platelet-derived microvesicles induce differential gene expression in monocytic cells: a DNA microarray study | Q40204179 | ||
| Aspirin improves endothelial dysfunction in atherosclerosis | Q42544568 | ||
| Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction | Q43029801 | ||
| P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain | Q43917782 | ||
| LPS-induced platelet response and rapid shock in mice: contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system | Q44182927 | ||
| Human endothelial impairment in sepsis | Q44283078 | ||
| Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. | Q44703978 | ||
| Early endotoxin-mediated haemostatic and inflammatory responses in the clopidogrel-treated pig. | Q46763608 | ||
| Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers | Q46830648 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 50-57 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Platelets | Q1573582 |
| P1476 | title | Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms | |
| P478 | volume | 20 |
| Q38075209 | Acute pneumonia and the cardiovascular system. |
| Q99629654 | Antiplatelet Agents in Sepsis-Putting it all together: A Call to Action |
| Q37598223 | AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol |
| Q35211647 | Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis |
| Q35916354 | Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study |
| Q41365182 | Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study |
| Q33752498 | Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients |
| Q33394357 | Beyond thrombosis: the versatile platelet in critical illness |
| Q35952453 | Blockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis |
| Q47096645 | Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients? |
| Q43098741 | Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel |
| Q30415074 | Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness |
| Q39114910 | Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? |
| Q36018451 | Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-Analysis |
| Q30244785 | Effect of antiplatelet therapy on mortality and acute lung injury in critically ill patients: A systematic review and meta-analysis |
| Q45097939 | Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock |
| Q44367120 | Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke. |
| Q33864069 | Inflammation and thrombosis in cardiovascular disease. |
| Q40896463 | Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice. |
| Q38165517 | Lipid mediators in immune dysfunction after severe inflammation |
| Q34456208 | Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study |
| Q35088200 | Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin. |
| Q38005318 | Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis. |
| Q35197476 | No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary disease |
| Q89860277 | P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation |
| Q27013790 | PAMPs and DAMPs as triggers for DIC |
| Q38151563 | Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. |
| Q34298556 | Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape. |
| Q84192794 | Platelet aggregation in severe sepsis |
| Q91962280 | Platelets Are Critical Key Players in Sepsis |
| Q47144868 | Platelets and Multi-Organ Failure in Sepsis |
| Q34590168 | Platelets as immune mediators: Their role in host defense responses and sepsis |
| Q28481577 | Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade |
| Q26853685 | Pneumonia, thrombosis and vascular disease |
| Q58992325 | Predictors of Disseminated Intravascular Coagulation in Patients with Septic Shock |
| Q33801302 | Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia |
| Q38629029 | Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching. |
| Q33894675 | Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study |
| Q55018714 | The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis. |
| Q34277327 | The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness |
| Q58698782 | Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia |
| Q33409092 | Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis |
| Q50115928 | Translational Implications of Platelets as Vascular First Responders |
| Q64086271 | Treatment With Acetylsalicylic Acid Reverses Endotoxin Tolerance in Humans In Vivo: A Randomized Placebo-Controlled Study |
| Q36928258 | Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis |
Search more.